Content area

1007133
Subject
Enrollments;
GAAP;
Metastasis;
Cancer therapies;
Earnings per share;
Esophageal cancer;
Leadership;
Oncology;
Research & development--R&D;
Corporate profits;
Hematology;
Market shares;
Drug dosages;
Lung cancer;
FDA approval;
Operating leverage;
Financial performance;
Chemotherapy;
Profitability
Business indexing term
Location
Europe; Switzerland; United States--US; China; Japan
Company / organization
Name:
BeiGene Ltd
NAICS:
325412
Title
BEIGENE LTD 20 MAY 2025_EN
Publication title
Company SnapShot; Yass
Publication year
2025
Publication date
May 20, 2025
Publisher
Acquisdata Pty Ltd
Place of publication
Yass
Country of publication
Australia
Publication subject
Business And Economics
e-ISSN
22032746
Source type
Report
Language of publication
English
Document type
Company Profile
Document feature
Company description; Company financials; Company competitors
ProQuest document ID
3206805249
Document URL
https://www.proquest.com/reports/beigene-ltd-20-may-2025-en/docview/3206805249/se-2?accountid=208611
Copyright
Copyright (c) 2025 Acquisdata Pty Ltd
Last updated
2025-05-27
Database
ProQuest One Academic